| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.26 | 4e-06 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-06 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.21 | 0.0007 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |